2012-03-19 Rx Conf Call
Jump to navigation Jump to search
- Chair – Melva Peters
- Scribe – John Hatem
- Hugh Glover
- Tim Buxton
- Derrick Evans
- Tom de Jong
- Tom discussed the Meaningful Use email, and will take the action item to send it to the Rx list.
- This issue will be discussed next week.
- Please review in preparation for a discussion next week.
- General Ballot Issues
- Encoded Order Storyboard – Melva asked if anyone had any new feedback on this storyboard. There were no comments and it was agreed the next round of feedback we expected would come via the normal ballot comments process.
- Melva reported on discussions with Jean Duteau – Jean is on target for getting our ballot material content updated and to HL7 on time.
- Hugh asked if we have any renumbering issues. Melva took an action item to contact Jean and have him contact Hugh to work this issue.
IDMP Ballot Dispositions
- see Ballot spreadsheets for comments and ballot dispositions.
- Group 1 – FDA issues that are Persuasive or Persuasive with Mod. After review and discussion there was a motion to accept the dispositions by Tom de Jong; Seconded by Tim Buxton Vote Passed: 4:0:0
- Group 2 – FDA issues that are Not Persuasive. After review and discussion there was a motion to accept the dispositions by Tim Buxton; Seconded by Derrick Evans. Vote Passed: 5:0:0
- Group 3 – Bill Friggle issues that are Persuasive. After review and discussion there was a motion to accept the dispositions by John Hatem; Seconded by Tim Buxton. Vote Passed: 5:0:0
- Group 4 – Bill Friggle issue that was Non Persuasive. After review and discussion there was a motion to accept the dispositions by Tim Buxton; Seconded by Derrick Evans. Vote Passed: 4:0:1
- Group 5 – Mead Walker negative issue. After review and discussion, there was a motion by Tom de Jong to accept the disposition; Seconded by Tim Buxton. Vote Passed: 5:0:0
CPM deprecating ‘lotnumber text’
- Tom raised this as a discussion in order to adequately respond to Julie’s request for more feedback.
- Tom will email Julie with the results of our discussions.
- We agreed that treating this attribute as Optional in our Universal ballot materials made sense, with some comments that we should update our Implementation Guidance section with examples on how “grouping” works for this attribute. Grouping means – that many instances of medications that are administered may come from the same product group with the same lot number. There are exceptions to this that were noted as well e.g. blood products in some cases are each documented with a “lot number”. .
- Derrick reported that he has incorporated the HL7 definitions he could find from the HL7 Glossary.
- He proposed that we use content from reputable dictionaries for the next round of updates to the glossary. There was general agreement with this approach.
- Harmonization Proposals
- No discussion this week.
- Clinical Statement
- At the OOC Jean and John agreed to meet separately on this topic to assess further updates.